东方生物(688298.SH)前三季度净亏损2.13亿元

Core Viewpoint - Dongfang Biological (688298.SH) reported a total operating revenue of 672 million yuan for the first three quarters of 2025, reflecting a year-on-year increase of 2.16% [1] - The net profit attributable to shareholders of the parent company was -213 million yuan, which represents a reduction in losses by 49.52 million yuan compared to the same period last year [1] - The basic earnings per share stood at -1.1 yuan [1] Financial Performance - Total operating revenue for the first three quarters reached 672 million yuan, marking a 2.16% increase year-on-year [1] - The net profit attributable to the parent company's shareholders was -213 million yuan, indicating a significant reduction in losses by 49.52 million yuan compared to the previous year [1] - Basic earnings per share were reported at -1.1 yuan [1]